Abstract
Obesity is an established risk factor for many cancers and is thought to adversely affect disease outcomes. Alterations in estrogen and other hormone metabolism in the obese have been postulated to increase the risk of gynecologic malignancies, including uterine and ovarian cancers. The impact of significant and sustained weight loss as achieved by bariatric surgery on gynecologic cancers is not well understood.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
